Jelinek J - Search Results

1

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate.

Issa JP, Gharibyan V, Cortes J, Jelinek J, Morris G, Verstovsek S, Talpaz M, Garcia-Manero G, Kantarjian HM. Issa JP, et al. Among authors: jelinek j. J Clin Oncol. 2005 Jun 10;23(17):3948-56. doi: 10.1200/JCO.2005.11.981. Epub 2005 May 9. J Clin Oncol. 2005. PMID: 15883410 Clinical Trial.

2

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia.

Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S, Beran M, Estey E, Kantarjian HM, Issa JP. Jelinek J, et al. Blood. 2005 Nov 15;106(10):3370-3. doi: 10.1182/blood-2005-05-1800. Epub 2005 Jul 21. Blood. 2005. PMID: 16037387 Free PMC article.

3

Silencing of bidirectional promoters by DNA methylation in tumorigenesis.

Shu J, Jelinek J, Chang H, Shen L, Qin T, Chung W, Oki Y, Issa JP. Shu J, et al. Among authors: jelinek j. Cancer Res. 2006 May 15;66(10):5077-84. doi: 10.1158/0008-5472.CAN-05-2629. Cancer Res. 2006. PMID: 16707430

4

Mutations and promoter methylation status of NPM1 in myeloproliferative disorders.

Oki Y, Jelinek J, Beran M, Verstovsek S, Kantarjian HM, Issa JP. Oki Y, et al. Among authors: jelinek j. Haematologica. 2006 Aug;91(8):1147-8. Epub 2006 Jul 25. Haematologica. 2006. PMID: 16870548

5

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K, Dressman HK, Jelinek J, Issa JP. Gollob JA, et al. Among authors: jelinek j. Clin Cancer Res. 2006 Aug 1;12(15):4619-27. doi: 10.1158/1078-0432.CCR-06-0883. Clin Cancer Res. 2006. PMID: 16899610 Clinical Trial.

6

Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence.

Kim J, Kim JY, Song KS, Lee YH, Seo JS, Jelinek J, Goldschmidt-Clermont PJ, Issa JP. Kim J, et al. Among authors: jelinek j. Biochim Biophys Acta. 2007 Jan;1772(1):72-80. doi: 10.1016/j.bbadis.2006.10.004. Epub 2006 Oct 12. Biochim Biophys Acta. 2007. PMID: 17110088 Free article.

7

Polycythemia vera is not initiated by JAK2V617F mutation.

Nussenzveig RH, Swierczek SI, Jelinek J, Gaikwad A, Liu E, Verstovsek S, Prchal JF, Prchal JT. Nussenzveig RH, et al. Among authors: jelinek j. Exp Hematol. 2007 Jan;35(1):32-8. doi: 10.1016/j.exphem.2006.11.012. Exp Hematol. 2007. PMID: 17198871 Free article.

8

RPS19 and JAK2 genes are not silenced by DNA methylation in diamond blackfan anemia.

Jelinek J, Issa JP, He R, Cmejla R, Cmejlova J, Pospisilova D. Jelinek J, et al. J Pediatr Hematol Oncol. 2007 Mar;29(3):207-8. doi: 10.1097/MPH.0b013e318033a75a. J Pediatr Hematol Oncol. 2007. PMID: 17356406 No abstract available.

9

LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability.

Estécio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP. Estécio MR, et al. Among authors: jelinek j. PLoS One. 2007 May 2;2(5):e399. doi: 10.1371/journal.pone.0000399. PLoS One. 2007. PMID: 17476321 Free PMC article.

10

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.

Beran M, Wen S, Shen Y, Onida F, Jelinek J, Cortes J, Giles F, Kantarjian H. Beran M, et al. Among authors: jelinek j. Leuk Lymphoma. 2007 Jun;48(6):1150-60. doi: 10.1080/10428190701216386. Leuk Lymphoma. 2007. PMID: 17577778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters